![](/img/cover-not-exists.png)
P-325 * A Phase II trial using a combination of Oxaliplatin, Capecitabine, and Celecoxib with concurrent radiation for newly diagnosed resectable rectal cancer: COX2 expression in relationship to outcomes
Araujo-Mino, E., Murray-Krezan, C., Patt, Y., Liem, B., Lee, F.- C.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv233.321
Date:
June, 2015
File:
PDF, 30 KB
english, 2015